FilingSEC EDGAR8-K
FibroBiologics Completes $0.5 Million Private Placement with CSO
· SEC accepted
StageFinancing Closed
Filing content
The company completed a $0.5 million private placement with its Chief Scientific Officer, Hamid Khoja, Ph.D., which closed on September 15, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…